BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20070778)

  • 1. Re: Rituximab for refractory head and neck Wegener's granulomatosis.
    Ibrahim AS
    Clin Otolaryngol; 2009 Dec; 34(6):581-2. PubMed ID: 20070778
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic crusting, nasal carriage of Staphylococcus aureus and relapse rate in pulmonary Wegener's granulomatosis.
    Zycinska K; Wardyn KA; Zielonka TM; Demkow U; Traburzynski MS
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():825-31. PubMed ID: 19218710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective therapeutic use of rituximab in refractory Wegener's granulomatosis.
    Ferraro AJ; Day CJ; Drayson MT; Savage CO
    Nephrol Dial Transplant; 2005 Mar; 20(3):622-5. PubMed ID: 15735243
    [No Abstract]   [Full Text] [Related]  

  • 4. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
    Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
    Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory Wegener's meningitis treated with rituximab.
    Bawa S; Mukhtyar C; Edmonds S; Webley M
    J Rheumatol; 2007 Apr; 34(4):900-1. PubMed ID: 17407257
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab and Wegener's granulomatosis: are B cells a target in vasculitis treatment?
    Sneller MC
    Arthritis Rheum; 2005 Jan; 52(1):1-5. PubMed ID: 15641069
    [No Abstract]   [Full Text] [Related]  

  • 7. Infliximab efficiency in refractory Wegener's granulomatosis.
    Rozin A
    Rheumatology (Oxford); 2003 Sep; 42(9):1124-5; author reply 1125-6. PubMed ID: 12923277
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of rituximab in Wegener's granulomatosis: comment on the article by Wong.
    Sánchez-Cano D; Callejas-Rubio JL; Ríos-Fernández R; Ortego-Centeno N
    Nephrol Dial Transplant; 2007 Mar; 22(3):958-9; author reply 959. PubMed ID: 17237478
    [No Abstract]   [Full Text] [Related]  

  • 9. Wegener's granulomatosis triggered by infection?
    Boudewyns A; Verbelen J; Koekelkoren E; Van Offel J; Van de Heyning P
    Acta Otorhinolaryngol Belg; 2001; 55(1):57-63. PubMed ID: 11256193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
    Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
    Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
    Seo P; Specks U; Keogh KA
    J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
    Mukhtyar C; Luqmani R
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv31-6. PubMed ID: 16239383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of Wegener's granulomatosis with de novo intraoral presentation treated successfully with rituximab.
    Staines KS; Higgins B
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul; 108(1):76-80. PubMed ID: 19451001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of the problem of Wegener's granulomatosis].
    Daĭniak LB; Minchin RA
    Vestn Otorinolaringol; 1984; (2):45-52. PubMed ID: 6324444
    [No Abstract]   [Full Text] [Related]  

  • 15. [Infliximab in the treatment of Wegener's granulomatosis: case report].
    Svozílková P; Ríhová E; Brichová M; Diblík P; Kuthan P; Poch T
    Cesk Slov Oftalmol; 2006 Jul; 62(4):280-6. PubMed ID: 16895062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for refractory Wegener's granulomatosis: a role for rituximab?
    Antoniu SA
    Curr Opin Investig Drugs; 2007 Nov; 8(11):927-32. PubMed ID: 17979026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease.
    Sánchez-Cano D; Callejas-Rubio JL; Ortego-Centeno N
    J Clin Rheumatol; 2008 Apr; 14(2):92-3. PubMed ID: 18391678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wegener's granulomatosis of the head and neck.
    Govett GS; Amedee RG
    J La State Med Soc; 1990 May; 142(5):13-6. PubMed ID: 2189015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infectious aspects of Wegener's granulomatosis].
    Rusterholz D; Schlegel C
    Schweiz Med Wochenschr; 2000; Suppl 125():41S-43S. PubMed ID: 11141937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab as rescue therapy in three cases of paediatric Wegener's granulomatosis.
    Wilkinson NM; Erendzhinova E; Zeft A; Cabral DA
    Rheumatology (Oxford); 2006 Aug; 45(8):1047-8. PubMed ID: 16735453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.